2m 2m 2m 2m 2m 2m 2m
Masimo (MASI)
NASDAQ
$178.77+$0.04 (+0.02%)
Price as of Jun 03, 2026 5:11 PM EDT- $9.3BMarket Cap
- 9.09%1-Year Change
- Medical DevicesIndustry
Masimo (MASI)
$178.77+$0.04 (+0.02%)
Annual
Quarterly
01/03/2026 | 12/28/2024 | 12/30/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.4B -32.75% | 2.1B +2.26% | 2.0B +65.28% | 1.2B +8.34% | |
Cost of Revenue | 581.7M -46.63% | 1.1B +4.35% | 1.0B +6.92% | 977.0M +143.84% | |
Gross Profit | 945.2M -5.89% | 1.0B +0.09% | 1.0B -5.22% | 1.1B +42.49% | |
Sales and Marketing Expense | 506.0M -31.97% | 743.8M +12.02% | 664.0M +5,298.37% | 12.3M -60.06% | |
Research and Development Expense | -126.4M -43.27% | -222.8M +27.17% | -175.2M -8.46% | -191.4M +61.30% | |
Depreciation and Amortization Expense | 38.8M -62.33% | 103.0M +4.78% | 98.3M -27.77% | 136.1M +364.51% | |
Total Operating Expenses | 635.2M -50.03% | 1.3B +46.61% | 867.0M +2.14% | 848.8M +74.21% | |
Operating Profit | 310.0M +216.24% | -266.7M -295.38% | 136.5M -35.00% | 210.0M -17.91% | |
Interest Income | 3.4M -29.17% | 4.8M +60.00% | 3.0M +66.67% | 1.8M -67.47% | |
Interest Expense | N/A N/A | -41.2M -18.09% | -50.3M +95.72% | -25.7M +7,503.55% | |
Interest Income and Expense and Net | 3.4M +109.34% | -36.4M -23.04% | -47.3M +97.91% | -23.9M -559.97% | |
Total Nonoperating Income and Expense | -37.4M -3.11% | -38.6M -20.25% | -48.4M +191.57% | -16.6M -309.78% | |
Income before Taxes | 272.6M +189.29% | -305.3M -446.54% | 88.1M -38.61% | 143.5M -40.28% | |
Income Taxes | 64.9M +16,325.00% | -400,000 -106.06% | 6.6M +116.79% | -39.3M +691.70% | |
Extraordinary Items | N/A N/A | 304.0M +2,940.00% | 10.0M N/A | N/A N/A | |
Net Income | -151.5M -50.31% | -304.9M -474.11% | 81.5M -43.21% | 143.5M -40.28% | |
Net Income from Continuing Operations Applicable to Common | 207.7M +168.03% | -305.3M -446.54% | 88.1M -38.61% | 143.5M -40.28% | |
Basic EPS and Net Income | -2.83 -50.52% | -5.72 -471.43% | 1.54 -42.54% | 2.68 -38.95% | |
Diluted EPS and Net Income | -2.80 -51.05% | -5.72 -478.81% | 1.51 -41.92% | 2.60 -37.20% | |
Basic Weighted Average Shares | 53.6M +0.56% | 53.3M +0.95% | 52.8M -1.49% | 53.6M -2.01% | |
Diluted Weighted Average Shares | 54.2M +1.69% | 53.3M -1.48% | 54.1M -1.99% | 55.2M -4.89% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 152.3M -14.25% | 177.6M +8.96% | 163.0M -19.66% | 202.9M -68.37% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 152.3M -14.25% | 177.6M +8.96% | 163.0M -19.66% | 202.9M -68.37% | |
Total Current Assets | 926.0M -24.46% | 1.2B -0.50% | 1.2B -5.86% | 1.3B +18.84% | |
Accumulated Depreciation | 316.2M +6.75% | 296.2M +12.88% | 262.4M +30.22% | 201.5M +50.22% | |
Property and Plant and Equipment and Net | 355.1M -6.94% | 381.6M -10.08% | 424.4M +5.44% | 402.5M +47.70% | |
Total Long-Term Assets | 44.7M -55.34% | 100.1M +12.09% | 89.3M -21.67% | 114.0M +155.36% | |
Total Assets | 1.7B -35.30% | 2.6B -13.67% | 3.0B -5.27% | 3.2B +87.47% | |
Income Taxes Payable | 200,000 -99.80% | 100.1M -10.38% | 111.7M -31.72% | 163.6M +645.09% | |
Total Short-Term Debt | 536.9M -36.07% | 839.8M -13.83% | 974.6M -45.58% | 1.8B +48,898.63% | |
Total Current Liabilities | 371.6M -39.84% | 617.7M +9.56% | 563.8M -10.51% | 630.0M +169.42% | |
Total Long-Term Debt | 518.0M -28.84% | 727.9M -16.50% | 871.7M -7.42% | 941.6M N/A | |
Total Long-Term Liabilities | 87.8M -31.46% | 128.1M -1.08% | 129.5M -5.13% | 136.5M +92.05% | |
Total Liabilities | 977.7M -37.88% | 1.6B -6.14% | 1.7B -10.42% | 1.9B +513.85% | |
Retained Earnings | 1.3B -10.16% | 1.5B -16.98% | 1.8B +4.75% | 1.7B +27.82% | |
Total Stockholders Equity | 721.2M -31.44% | 1.1B -22.93% | 1.4B +1.93% | 1.3B -4.88% | |
Total Shares Outstanding | 52.1M -2.80% | 53.6M +1.52% | 52.8M +0.57% | 52.5M -4.98% | |
Cash Flow | |||||
Cash from Operating Activities | 217.8M +10.90% | 196.4M +108.71% | 94.1M +220.07% | 29.4M -86.06% | |
Capital Expenditures | 19.4M -3.00% | 20.0M -54.55% | 44.0M -16.67% | 52.8M -27.22% | |
Cash from Investing Activities | 275.1M +637.30% | -51.2M -36.95% | -81.2M -92.32% | -1.1B +1,177.62% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -520.7M +314.57% | -125.6M +119.96% | -57.1M -110.97% | 520.4M +1,058.26% | |
Financials Ratio | |||||
Gross Margin | 58.70% +22.40% | 47.96% -2.12% | 49.00% N/A | N/A N/A | |
Operating Margin | 22.01% +272.85% | -12.73% -291.07% | 6.66% N/A | N/A N/A | |
Return on Assets | -7.01% -34.89% | -10.76% -512.73% | 2.61% N/A | N/A N/A | |
Return on Equity | -17.09% -32.28% | -25.23% -518.54% | 6.03% N/A | N/A N/A | |
Revenue Growth | -32.75% -1,548.91% | 2.26% -96.54% | 65.28% N/A | N/A N/A | |
Current Ratio | 2.49 +25.57% | 1.98 -9.18% | 2.19 N/A | N/A N/A | |
Cash Ratio | 0.41 +42.54% | 0.29 -0.55% | 0.29 N/A | N/A N/A | |
Debt-to-Equity Ratio | 1.46 -1.86% | 1.49 +10.17% | 1.35 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.62 +3.99% | 0.60 -1.63% | 0.61 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow